SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as community members express bullish sentiment and anticipate a breakout, particularly around the $200 mark. Discussions also involve various Solana-based meme coins like $WAGMI and $SOLYCAT, reflecting interest in the Solana ecosystem. Some traders are eyeing potential short squeezes and retesting of resistance levels.

Pump.fun

$PUMP is gaining attention, with community members actively buying and expressing enthusiasm. Much of the discussion revolves around the $SOL ecosystem and the sentiment that 'We Are All Gonna Make It' ($WAGMI). Some users believe $PUMP has the potential for significant growth, drawing comparisons to other successful tokens.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as community members highlight its resilience and stable market capitalization within the Solana ecosystem. Talk centers on the token's potential for significant revaluation, driven by strong holder growth and expanding visibility. The community emphasizes a long-term vision, focusing on building and holding.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

$401JK is trending due to its community's focus on challenging traditional retirement systems and promoting the idea of financial freedom through crypto. Community members are actively discussing the token's potential to disrupt conventional 401(k) plans and create a new path to early retirement, emphasizing its strong community and organic growth on the Solana blockchain.

Trump For President

The $TRUMP crypto token is trending amid renewed focus on political hype coins, spurred by recent poll headlines, leading to increased volatility. The community's discussion varies wildly, ranging from strong support tied to the 'MAGA' movement and the upcoming election to harsh criticism, including accusations of being a 'creepy PEDO cult stock' or a 'scam'. Additionally, potential consensus between U.S. and China officials regarding rare earth elements and tariffs, involving Trump and Xi, may also be contributing to the current interest.

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Avidity Biosciences Inc

Avidity Biosciences ($RNA) is trending amid speculation of a potential acquisition, with community members highlighting positive trial data and a strong cash position. The stock is seeing increased interest and unusual options activity, leading to discussions about a possible buyout by Novartis ($NVS) or other major pharmaceutical players. Despite some skepticism and recent insider selling, many investors remain bullish, citing analyst price targets and the potential for significant gains in the muscular dystrophy treatment space.

Shibmas was launched on the 9th Of December. The project is a meme token and gives homage to Shiba Inu the token. The token is a playful character who is bringing the Christmas spirit to token holders all around the world. We plan on getting many listings on various exchanges in the coming days. We have over 1000 holders in 24 hours and we aim on getting over 10000 holders within the next week and in the run up to Christmas

Shibmas

Shibmas ($SMAS) is gaining attention, particularly within the Phantom Wallet community, as traders discuss its potential for a breakout. Bullish sentiment is fueled by perceived positive chart patterns and strong momentum, with many highlighting its potential for rapid gains. The crypto is currently testing resistance levels, leading to increased monitoring of volume.

WorldFinancial

World Financial ($WLFI) is trending amid community discussions around its DeFi banking potential and speculation about institutional adoption. Some see it as a next-generation crypto narrative focused on regulatory compliance, while others express skepticism, citing centralization concerns. Bullish sentiment appears linked to perceived affiliations with prominent figures and potential for real-world asset tokenization.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending amid ongoing speculation about a potential acquisition of Warner Bros. Discovery, with community chatter focusing on deal terms and potential bidding wars. Some investors believe a merger would create a media powerhouse, while others express concerns about overpaying or regulatory hurdles, with some suggesting PSKY should focus on its own growth and AI integration.

Binance Coin is the cryptocurrency of the Binance platform. It is a trading platform exclusively for cryptocurrencies. The name "Binance" is a combination of binary and finance.  Thus, the startup name shows that only cryptocurrencies can be traded against each other. It is not possible to trade crypto currencies against Fiat. The platform achieved an enormous success within a very short time and is focused on worldwide market with Malta headquarters. The cryptocurrency currently has a daily trading volume of 1.5 billion - 2 billion US dollars and is still increasing.  In total, there will only be 200 million BNBs. Binance uses the ERC20 token standard from Ethereum and has distributed it as follow: 50% sold on ICO, 40% to the team and 10% to Angel investors. The coin can be used to pay fees on Binance. These include trading fees, transaction fees, listing fees and others. Binance gives you a huge discount when fees are paid in BNB.   The schedule of BNB fees discount is as follow: In the first year, 50% discount on all fees, second year 25% discount, third year 12.5% discount, fourth year 6.75 % discount, and from the fifth year onwards there is no discount. This structure is used to incentivize users to buy BNB and do trades within Binance.  Binance announced in a buyback plan that it would buy back up to 100 million BNB in Q1 2018. The coins are then burned. This means that they are devaluated to increase the value of the remaining coins. This benefits investors. In the future, the cryptocurrency will remain an asset on the trading platform and will be used as gas.  Other tokens that are issued by exchanges include Bibox Token, OKB, Huobi Token, and more.

Binance

BNB is trending as the crypto market shows signs of an altcoin season, with the token hitting new all-time highs and community members expressing excitement about potential future gains. Bullish sentiment is fueled by technical analysis suggesting further upside, and discussions around strategic acquisitions of BNB. Despite positive sentiment, concerns about market manipulation and the centralized nature of BNB are also being actively debated.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Tharimmune (THAR) Shares Are Getting Hammered

Tharimmune shares are trading lower by 30% during Monday's session. The company late Friday announced it had entered into an 'at the market' offering agreement.
read more...

Why Tharimmune (THAR) Shares Are Moving

Tharimmune shares are trading lower by 16.4% during Wednesday's session. The company announced a 1-for-15 reverse stock split.
read more...

Short Interest in Tharimmune, Inc. (NASDAQ:THAR) Decreases By 69.9%

Tharimmune, Inc. (NASDAQ:THAR  Get Free Report) saw a large decrease in short interest in March. As of March 15th, there was short interest totalling 22,800 shares, a decrease of 69.9% from...

Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now

MIAMI, March 06, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 68th Emerging Growth Conference on March 6 & 7, 2024. The...

Tharimmune to Present at the Emerging Growth Conference on March 7, 2024

Tharimmune invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth ConferenceBRIDGEWATER, NJ...

Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now

MIAMI, March 05, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 68th Emerging Growth Conference on March 6 & 7, 2024. The...

Tharimmune Announces Positive Results in Phase 1 Clinical Trial of TH104, its Lead Clinical Therapeutic Candidate

Positive safety/tolerability profile achieved with TH104 showing self-resolving, mild side effect profile aligned with previous studiesPhase 1 clinical trial compared oral transmucosal delivery of...

Tharimmune doses first patient in Phase 1 trial of TH104

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Tharimmune Announces Dosing of First Patient in Phase 1 Clinical Trial of TH104, its Lead Candidate for Pruritus in Primary Biliary Cholangitis

Phase 1 clinical trial dosing of first patient complete; primary objective to assess safety/tolerability and absolute bioavailability of TH104Phase 1 study expected to be completed in 1Q24 with...

Tharimmune provides update on TH-3215, TH-1940 non clinical-stage programs

Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or uncontrollable itching in PBC, a rare and orphan liver disease with no known cure. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.

Tharimmune Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

THAR
Hillstream BioPharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest THAR News

THARHillstream BioPharma Inc